{
      "ptx_code": "PTX082",
      "chem_name": "Perfluorooctanoic acid",
      "casrn": "335-67-1",
      "dtxsid": "DTXSID8031865",
      "smiles": "OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F",
      "inchikey": "SNGREZUHAYWORS-UHFFFAOYSA-N",
      "label": "PTX082 | Perfluorooctanoic acid",
      "drugbank_id": "",
      "use_class": "Industry and consumer goods",
      "tox_class": "Immunotoxicity; Hepatotoxicity; Neurotoxicity; Genotoxicity",
      "chem_name_user": "PFOA",
      "mw_g_mol": "414.07",
      "solubility_h2o_mol_liter": "0.03",
      "source_solubility_h2o": "COMPTOX (OPERA)",
      "henry_coefficient_atm_m3_mol": "1.92e-10",
      "source_henry": "COMPTOX",
      "log_kaw_kh_rt": "8.11",
      "source_kaw": "Comptox",
      "pka_acid": "2.40",
      "pka_base": "",
      "source_pka": "UFZ; Sirius T3",
      "log_kow_liter_liter": "3.60",
      "source_kow": "Danish_EPA_SCPFAS_Report_2015",
      "log_dlipw_ph74_liter_liter": "3.52",
      "source_dlipw": "Ebert et al.  2020",
      "freely_dissolved_fraction": "0.19",
      "density_kg_liter": "",
      "source_density": "",
      "average_mass": "414.07",
      "boiling_point": "189.0 \u00b0C",
      "source_boiling_point": "SynQuest Labs (Chemical company)",
      "melting_point": "59.0 \u00b0C",
      "source_melting_point": "Alfa Aesar (Chemical company)",
      "vapor_pressure": "0.0165014 mmHg",
      "source_vapor_pressure": "Tetko et al, J Comput Aided Mol Des. 2011; 25(6):533-54",
      "baseline_drerio": "54.40",
      "baseline_dmagna": "44.30",
      "baseline_celegans": "97.63",
      "baseline_xlaevis": "54.73",
      "baseline_dmelanogaster": "379.37",
      "baseline_cells": "4.22e-05",
      "baseline_cells_generic_micromole_liter_free_ec10": "7.85e-06",
      "moa_drugbank": "",
      "protein_binding": "",
      "moa_t3db": "",
      "aop": [
            {
                  "AOP_id": 6,
                  "AOP_name": "Antagonist binding to PPAR\u03b1 leading to body-weight loss "
            },
            {
                  "AOP_id": 18,
                  "AOP_name": "PPAR\u03b1 activation in utero leading to impaired fertility in males "
            },
            {
                  "AOP_id": 19,
                  "AOP_name": "Androgen receptor antagonism leading to adverse effects in the male foetus (mammals) "
            },
            {
                  "AOP_id": 34,
                  "AOP_name": "LXR activation leading to hepatic steatosis "
            },
            {
                  "AOP_id": 36,
                  "AOP_name": "Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis "
            },
            {
                  "AOP_id": 57,
                  "AOP_name": "AhR activation leading to hepatic steatosis "
            },
            {
                  "AOP_id": 58,
                  "AOP_name": "NR1I3 (CAR) suppression leading to hepatic steatosis "
            },
            {
                  "AOP_id": 61,
                  "AOP_name": "NFE2L2/FXR activation leading to hepatic steatosis "
            },
            {
                  "AOP_id": 72,
                  "AOP_name": "Epigenetic modification of PPARG leading to adipogenesis "
            },
            {
                  "AOP_id": 131,
                  "AOP_name": "Aryl hydrocarbon receptor activation leading to uroporphyria "
            },
            {
                  "AOP_id": 187,
                  "AOP_name": "Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage "
            },
            {
                  "AOP_id": 200,
                  "AOP_name": "Estrogen receptor activation leading to breast cancer   "
            },
            {
                  "AOP_id": 318,
                  "AOP_name": "Glucocorticoid Receptor activation leading to hepatic steatosis "
            }
      ],
      "targets": [
            "Beta-secretase 1",
            "Cytochrome P450 2B6",
            "Cytochrome P450 3A4",
            "Estrogen receptor alpha",
            "Fas-binding factor 1",
            "Hydroxymethylglutaryl-CoA synthase, mitochondrial",
            "Nociceptin receptor",
            "Nuclear receptor subfamily 1 group I member 2",
            "Peroxisome proliferator-activated receptor alpha",
            "Peroxisome proliferator-activated receptor gamma",
            "Urokinase plasminogen activator surface receptor"
      ]
}